Lack of Late Acquired Incomplete Stent Apposition Following Implantation of the Endeavor™ Zotarolimus-Eluting Stent (ZES) in Unselected Patients with Complex Coronary Lesions - An Intravascular Ultrasound (IVUS) Study

被引：0
|
作者：
Costa, Ricardo A. [1 ]
Feres, Fausto [1 ]
Andrade, Pedro B. [1 ]
Costa, J. Ribamar, Jr. [1 ]
Abizaid, Alexandre [1 ]
Staico, Rodolfo [1 ]
Tanajura, Luiz F. [1 ]
Maia, Julio P. [1 ]
Sousa, Amanda [1 ]
Sousa, J. Eduardo [1 ]
机构：
[1] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2008年 / 102卷 / 8A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：210I / 211I
页数：2
相关论文
共 50 条
  • [31] The clinical evaluation of the Endeavor zotarolimus-eluting coronary stent in Japanese patients with de novo native coronary artery lesions: primary results and 3-year follow-up of the Endeavor Japan study
    Saito, Shigeru
    Prpic, Ross
    Popma, Jeffery J.
    Alexander, John
    Krucoff, Mitchell W.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2011, 12 (05) : 273 - 279
  • [32] Serial Intravascular Ultrasound Analysis of Complex Bifurcation Coronary Lesions Treated With the Tryton Bifurcation Stent in Conjunction With an Everolimus-Eluting Stent: IUVANT (Intravascular Ultrasound Evaluation of Tryton Stent) Study
    Bartorelli, Antonio L.
    Trabattoni, Daniela
    Almonacid, Alexandra
    Fabbiocchi, Franco
    Montorsi, Piero
    Galli, Stefano
    Grancini, Luca
    Ravagnani, Paolo
    Mintz, Gary S.
    Kaplan, Aaron V.
    Popma, Jeffrey J.
    Maehara, Akiko
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2015, 85 (04) : 544 - 553
  • [33] Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine encapsulated stent for treatment of native coronary artery lesions:: Clinical and angiographic results of the ENDEAVOR II trial
    Fajadet, Jean
    Wijns, William
    Laarman, Gert-Jan
    Kuck, Karl-Heinz
    Ormiston, John
    Munzel, Thomas
    Popma, Jeffrey J.
    Fitzgerald, Peter J.
    Bonan, Raoul
    Kuntz, Richard E.
    CIRCULATION, 2006, 114 (08) : 798 - 806
  • [34] Duration of clopidogrel-based dual antiplatelet therapy and clinical outcomes after endeavor sprint zotarolimus-eluting stent implantation in patients presenting with acute coronary syndrome
    Song, Pil Sang
    Hahn, Joo-Yong
    Kim, Doo-Il
    Song, Young Bin
    Choi, Seung-Hyuk
    Choi, Jin-Ho
    Ryu, Dong Ryeol
    Hur, Seung Ho
    Jeong, Jin-Ok
    Park, Hun Sik
    Kim, Hyo-Soo
    Gwon, Hyeon-Cheol
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2015, 26 (07) : 521 - 527
  • [35] Late Safety Efficacy, and Cost-Effectiveness of a Zotarolimus-Eluting Stent Compared With a Paclitaxel-Eluting Stent in Patients With De Novo Coronary Lesions 2-Year Follow-Up From the ENDEAVOR IV Trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary, Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)
    Leon, Martin B.
    Kandzari, David E.
    Eisenstein, Eric L.
    Anstrom, Kevin J.
    Mauri, Laura
    Cutlip, Donald E.
    Nikolsky, Eugenia
    O'Shaughnessy, Charles
    Overlie, Paul A.
    Kirtane, Ajay J.
    McLaurin, Brent T.
    Solomon, Stuart L.
    Douglas, John S., Jr.
    Popma, Jeffrey J.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (12) : 1208 - 1218
  • [36] The Relationship between Plaque Prolapse Phenomenon and Late Incomplete Stent Apposition after Sirolimus Eluting Stents Implantation in Patients with Acute Coronary Syndrome
    Mizuno, Tomofumi
    Takashima, Hiroaki
    Asai, Kenji
    Kuroda, Yasuo
    Wakita, Yoshinori
    Kousaka, Takashi
    Kuhara, Yasushi
    Kurita, Akiyoshi
    Maeda, Kazuyuki
    Wakida, Yasushi
    Ito, Takayuki
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 60I - 60I
  • [37] Neointima hyperplasia and angiographic late lumen loss after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients. The DiabeDES III study
    Jensen, L. O.
    Maeng, M.
    Thayssen, P.
    Villadsen, A.
    Botker, H. E.
    Ravkilde, J.
    Lassen, J. F.
    Hansen, K. N.
    Tilsted, H. H.
    Thuesen, L.
    EUROPEAN HEART JOURNAL, 2009, 30 : 788 - 788
  • [38] Optimal Duration of Dual Antiplatelet Therapy Following Treatment with the Endeavor Zotarolimus-Eluting Stent in Real-World Japanese Patients with Coronary Artery Disease (OPERA): Study Design and Rationale
    Nakamura, Masato
    Nanto, Shinsuke
    Hirayama, Atsushi
    Takayama, Tadateru
    Nishikawa, Masakatsu
    Kimura, Kazuo
    Morita, Satoshi
    Aizawa, Tadanori
    Asano, Ryuta
    Matsumaru, Yuji
    Hamada, Chikuma
    Isshiki, Takaaki
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2014, 84 (03) : 368 - 374
  • [39] Late-acquired incomplete stent apposition after everolimus-eluting stent versus sirolimus-eluting stent implantation in patients with non-ST-segment elevation myocardial infarction and ST-segment elevation myocardial infarction (APPOSITION-AMI)
    Hur, Seung-Ho
    Lee, Bong-Ryeol
    Kim, Sang Wook
    Hong, Young Joon
    Bae, Jang-Ho
    Choi, Donghoon
    Kang, Hyun-Jae
    Choi, So-Yeon
    Lee, Sang Gon
    Kim, Doo-Il
    Park, Jong-Seon
    Rha, Seung Woon
    EUROINTERVENTION, 2016, 12 (08) : E979 - E986
  • [40] Relation between late in-stent neointimal proliferation and residual plaque burden after drug-eluting stent implantation: an intravascular ultrasound study of cypher, taxus and endeavor stents
    Lee, C. H.
    Zhang, J.
    Kailasam, A.
    Tai, B. C.
    Ye, F.
    Low, A.
    Teo, S. G.
    Chen, S.
    Tan, H. C.
    Lim, Y. T.
    EUROPEAN HEART JOURNAL, 2008, 29 : 588 - 588
12345